Interested in becoming a principal researcher? Read this first.
Mark Packer, MD, FACS, CPI
Advertisement
Articles by Mark Packer, MD, FACS, CPI
Rho kinase inhibitors are intriguing in that they work directly on the pathogenic mechanism of abnormally elevated IOP, increased resistance to trabecular outflow.
Advertisement
Latest Updated Articles
- Directly targeting pathology: A novel approach to treating glaucoma
Published: June 15th 2015 | Updated:
- Pearls and pitfalls for principal investigators
Published: March 8th 2018 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
2
Horizon Surgical Systems performs first AI-assisted cataract surgery
3
Q&A: Inder Paul Singh, MD, explores technician empowerment via the Academy Technician Training Platform
4
Quantifying intermittent retinal capillary perfusion in RVO and PDR
5
.png "Optometry Times"){kind=logo}
